May 13, 2021 10:36 AM EDTUpdated 10:57 AM
News Briefing

AI life sci­ences uni­corn rais­es $150M for plat­form ops; 10 rare dis­ease com­pa­nies form new lob­by­ing group

John Carroll

Editor & Founder

Max Gelman

Senior Editor

Bain Cap­i­tal just en­dorsed the no­tion that AI and big da­ta are com­ing of age in the life sci­ences in­dus­try.

Their Tech Op­por­tu­ni­ties team is …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

Bris­tol My­ers re­veals more job cuts in New Jer­sey

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Mer­ck halts Phase 3 tri­al with PAH drug Win­re­vair fol­low­ing pos­i­tive in­ter­im da­ta 

In­cyte touts Mon­ju­vi da­ta from Phase 3 fol­lic­u­lar lym­phoma tri­al as it heads to FDA

Cas­sa­va shares plunge as con­tro­ver­sial Alzheimer’s drug fails Phase 3 tri­al

A service from the Financial Times